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Abstract
Rationale: Thymosin beta-4 (Tb4) is a ubiquitous protein with diverse functions relating to cell proliferation and
differentiation that promotes wound healing and modulates inflammatory responses. The effecter molecules targeted by
Tb4 for cardiac protection remains unknown. The purpose of this study is to determine the molecules targeted by Tb4 that
mediate cardio-protection under oxidative stress.
Methods: Rat neonatal fibroblasts cells were exposed to hydrogen peroxide (H2O2) in presence and absence of Tb4 and
expression of antioxidant, apoptotic and pro-fibrotic genes was evaluated by quantitative real-time PCR and western
blotting. Reactive oxygen species (ROS) levels were estimated by DCF-DA using fluorescent microscopy and fluorimetry.
Selected antioxidant and antiapoptotic genes were silenced by siRNA transfections in cardiac fibroblasts and the effect of
Tb4o nH 2O2-induced profibrotic events was evaluated.
Results: Pre-treatment with Tb4 resulted in reduction of the intracellular ROS levels induced by H2O2 in the cardiac
fibroblasts. This was associated with an increased expression of antioxidant enzymes Cu/Zn superoxide dismutase (SOD)
and catalase and reduction of Bax/Bcl2 ratio. Tb4 treatment reduced the expression of pro-fibrotic genes [connective tissue
growth factor (CTGF), collagen type-1 (Col-I) and collagen type-3 (Col-III)] in the cardiac fibroblasts. Silencing of Cu/Zn-SOD
and catalase gene triggered apoptotic cell death in the cardiac fibroblasts, which was prevented by treatment with Tb4.
Conclusion: This is the first report that exhibits the targeted molecules modulated by Tb4 under oxidative stress utilizing the
cardiac fibroblasts. Tb4 treatment prevented the profibrotic gene expression in the in vitro settings. Our findings indicate that Tb4
selectively targets and upregulates catalase, Cu/Zn-SOD and Bcl2,t h e r e b y ,p r e v e n t i n gH 2O2-induced profibrotic changes in the
myocardium. Further studies are warranted to elucidate the signaling pathways involved in the cardio-protection afforded by Tb4.
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Introduction
Reactive oxygen species (ROS) plays an important role in
regulating a variety of cellular functions, including gene expression,
cell growth and cell death and has been implicated as one of the
major contributorsof cardiac damageinvarious cardiac pathologies
[1,2,3]. Increased ROS levels can cause damage to nucleic acids,
lipids, and proteins and can directly damage the vascular cells,
cardiac myocytes and cardiac fibroblasts [3,4]. Oxidative stress has
been shown to be a precursor of cardiac apoptosis and has also been
implicated in cardiac hypertrophy and fibrosis [5,6,7]. The
declining protective enzymes and the reduced adaptive capacity
to counter the oxidative stress cause activation of apoptotic death
pathways [8]. Although, cells, tissues and organs utilize multiple
layers of antioxidant defenses and damage removal, the heart is
particularly more vulnerable to oxidative damage as it has a weak
endogenous antioxidant defense system [9].
It has been suggested that an increased level of oxidative stress
heart is primarily due to the functional uncoupling of the
respiratory chain caused by inactivation of complex I in the
mitochondria [10] or due to impaired antioxidant capacity, such
as reduced activity of Cu/Zn superoxide dismutase (Cu/Zn-SOD)
and catalase [6], or stimulation of enzymatic sources, including
xanthine oxidase, cyclo-oxygenase, nitric oxide synthase, and non-
phagocytic NAD(P)H oxidases [11]. Irrespective of the source of
the stress stimuli involved, oxidative damage remains the main
challenge and numerous efforts have been made to devise
strategies to protect the heart against oxidative damage.
Considerable attempts have been made in the recent decades to
discover an ‘‘ideal’’ cardio-protective agent, which can abrogate
the oxidative damage and maladaptive changes in the heart. In
this pursuit, thymosin b4( T b4) emerged as a powerful candidate.
Tb4, a 43 amino acids, ubiquitous intracellular protein, bind to
and sequester G- actin to modulate cell migration [12]. Recent
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pathological functions, such as wound healing, angiogenesis,
preserved cardiac function after myocardial infarction which
essentially depends on cell migration [13,14,15]. Essentially, Tb4
possesses cardiac tissue repair properties that cause epicardial cell
migration, neovascularization and revascularization, and activa-
tion of cardiac progenitor cells in the heart [16,17]. Apart from the
cardiac repair properties, it has been demonstrated that Tb4
protects human corneal epithelial cells and conjunctival cells from
apoptosis after ethanol and hydrogen peroxide (H2O2) injury
[18,19,20]. A few reports exhibit the role of Tb4 in the myocardial
infarction settings where it promotes endothelial and myocardial
cell survival, cardiac cell migration, activation of integrin linked
kinase (ILK) and activation of Akt/Protein Kinase B that resulted
in improved cardiac function and reduction in scarring [14,16,21].
In this context, we have shown that Tb4 also plays a crucial role in
cardiac protection by enhancing the levels of PINCH-1-ILK-a-
parvin components and promotes Akt activation while substan-
tially suppressing NF-kB activation [22]. A recent report showed
that Tb4 upregulates anti-oxidative enzymes in human corneal
cells against oxidative stress [23].
In this study, we used rat neonatal cardiac fibroblasts to study
the effects of Tb4 under oxidative stress. The rationale for using
cardiac fibroblasts in this study originates from the fact that apart
from being the most abundant cell type in the mammalian heart
[24,25,26], the fibroblasts are intricately involved in myocardial
development and cardiac protection under various stimuli [27,28].
Recently, it has been shown that cardiac fibroblasts also undergo
apoptosis under myocardial damage which can further aggravate
the myocardial injury [29] and this can occur independent of the
myocyte death [30]. The action of Tb4 on cardiac fibroblasts
under oxidative stress and its effects are largely unknown. It was
for this reason we utilized the cardiac fibroblasts in the in vitro
model to study the cardioprotective effects of Tb4 under oxidative
stress.
Here, we showed the effects of Tb4 on ROS act ivy, antioxidant
enzymes, anti-apoptotic and pro-fibrotic gene expression in
preventing H2O2 induced oxidative stress in rat cardiac fibroblasts.
Materials and Methods
Reagents
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), hydrogen peroxide (H2O2), dimethyl sulfoxide (DMSO),
5-Bromo-2-DeoxyUridine, (BrdU) all were purchased from Sigma
Life Science (St. Louis, MO, USA). Thymosin b4 was purchased
from ProSpec-Tany TechnoGene Ltd, (Rehovot, Israel). Dihy-
droethidium (DHE), 29,79-dichlorodihydrofluorescein diacetate
(H2DCFH-DA), diaminofluorescein 2-diacetate (DAF-2DA),
3,39-dihexyloxacarbocyanine iodide (DiOC6), and chloromethyl-
X-rosamine (MitoTracker Red), ProLong Gold anti-fade mount-
ing media (anti-fade) were purchased from Molecular Probes
(Eugene, OR, USA). Primary antibody for Mn-SOD was
purchased from Upstate/Millipore (Billerica, MA, USA); Cu/
Zn-SOD from Assay Designs Inc., (Ann Arbor, MI, USA); catalase
from Santa Cruz Biotechnology (Santa Cruz, CA, USA); collagen
type I and collagen type III from Rockland Immunochemicals,
(Gilbertsville, PA, USA); connective tissue growth factor (CTGF)
from Abcam Inc. (Cambridge, MA, USA), Bax, Bcl2, caspase-3
and GAPDH were purchased from Cell Signaling Technology
(Beverly, MA, USA). Protease inhibitor cocktail tablets were
purchased from Roche GmbH, (Mann-heim, Germany). Dulbec-
co’s Modified Eagle Medium (DMEM), non-essential amino acid
cocktail, Antibiotic and anti-mycotic solution, insulin, transferrin
and selenium (ITS), and fetal Bovine Serum (FBS) were all
purchased from GIBCO, Invitrogen (Carlsbad, CA, USA).
Cell culture and treatment
Primary cultures of cardiac fibroblasts were prepared from
ventricles of 1–3 day-old Wistar rats as described [31,32] and were
plated at a field density of 2.5610
4 cells per cm
2 on coverslips, 6-
well plates, 60 mm culture dishes, or 100 mm dishes as required
with DMEM containing 10% FBS. After 24 h, cells were serum
deprived overnight before stimulation. The dose of 100 mMH 2O2
did not show any toxic effect and damage to the cells and was
therefore used throughout the study. Tb4 was pretreated 2 h
before the H2O2 challenge at a final concentration of 1 mg/mL
which was based on the previous report [23]. The cardiac cell
culture experiments were approved by Institutional Biosafety
Committee (IBC) and IACUC, Texas A & M University, Temple,
TX.
Standardization of H2O2 dose on cardiac fibroblasts
To determine the optimal sub-lethal working concentration of
H2O2 that is sufficient to induce oxidative stress but does not cause
considerable cell death, the cell viability of cardiac fibroblasts
under oxidative stress using a dose course of H2O2 (1 to 250 mM)
was evaluated by MTT assay as described [33]. The absorbance
was measured at 570 nm using a microplate reader (Molecular
Devices, SpectraMax 250). The effect of Tb4( 1 mg/mL) was
assessed on the H2O2 challenge and the cytotoxicity curve was
constructed and expressed as percentage cell viability compared to
control. To rule out the possible direct interaction between MTT
with H2O2 or Tb4, the treatment media was aspirated before the
addition of MTT solution.
Quantification of intracellular ROS levels
Cardiac fibroblasts after respective treatments were incubated
with 50 mMH 2DCFH-DA at 37uC in the dark for 30 min as
described [33]. To rule out the possible direct cleavage of non-
fluorescent DCFH-DA to fluorescent DCF by the nonspecific
intracellular esterases and extracellular esterases in the serum, the
treatment media was completely removed before H2DCFH-DA
staining. Cells were then harvested, washed with phosphate-
buffered saline (PBS), and re-suspended in 50 mM HEPES buffer
(5 mM HEPES, pH 7.4; 5 mM KCl, 140 mM NaCl, 2 mM
CaCl2, 1 mM MgCl2 and 10 mM glucose) before their fluores-
cence intensities were acquired by fluorimetry (SpectraMaxPro,
USA).
Confocal Microscopy
For qualitative estimation of the levels of intracellular ROS,
cells were seeded on coverslips in 6-well plates, treated and
subsequently incubated with 50 mMH 2DCFH-DA at 37uC in the
dark for 30 min as previously described [33]. Cells were then fixed
with 2% paraformaldehyde, washed 3 times with PBS, and
mounted using anti-fade on glass slides and observed under
confocal laser scanning microscope (Fluoview FV1000) fitted with
a 488 nm argon ion laser. Images were acquired using the F10-
ASW 1.5 Fluoview software (Olympus, Tokyo, Japan). Since,
ROS induces generation of other ROS species and loss of
mitochondrial membrane potential, we estimated the levels of
other free radicals like superoxide and nitric oxide using
fluorescent probes. For this, DHE, DAF-2DA and MitoTracker
Red were used for estimation of superoxide (O2
.-) radicals, nitric
oxide (NO) and mitochondrial membrane potential (Dym),
respectively [33]. Image intensities from 15–20 fields of at least
Thymosin Beta 4 Prevents Oxidative Stress
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e269123–4 confocal images of the same treatment group were quantified
using ImageJ version 1.34 (NIH, Bethesda, USA) as described
previously by Elia et. al.[34]
Western blot analysis
For western blot analysis, cardiac fibroblasts were treated with
or without Tb4 for 2 h before treatment with 100 mMo fH 2O2.
Cells were washed with PBS and cytosolic protein extracts were
prepared using 1X Cell Lysis buffer (Santa Cruz Biotechnology,
CA, USA) supplemented with protease inhibitor cocktail. Protein
concentrations were determined using the Bradford assay (Bio-
Rad) as per manufacturer’s protocol. Aliquots of protein lysates
(40 mg/lane) were separated on sodium dodecyl sulfate–10%
polyacrylamide gels and western blotting was performed as
described previously [31]. The primary antibodies used in this
study include Mn-SOD, Cu/Zn-SOD, catalase, Bcl2, Bax,
Caspase-3, Col-I, Col-III, CTGF and GAPDH. The detection
was performed using chemiluminescence assay (Cell Signaling
Technology, Beverly, MA). Membranes were exposed to x-ray film
to observe the bands (Kodak, Rochester, NY). The quantification
of each western blot was measured by densitometry as described
previously [31]. The changes observed as a result of H2O2
stimulation were expressed as fold change while the changes
observed as a result of Tb4 treatment were depicted as percent
increase or decrease unless otherwise noted.
RNA isolation and quantitative real-time PCR (q-RT-PCR)
analyses
Total RNAs from the cardiac fibroblasts were extracted using
RNEasy kit (Qiagen, Stanford, Valencia, CA) as per the
manufacturer’s instructions. For real-time RT-PCR, 200 ng to
1 mg of total RNAs was reverse transcribed to cDNA using high
capacity cDNA synthesis kit (Applied Bio systems, Foster City, CA,
USA) following the manufacturer’s protocols. Quantitative PCR
was then carried out in a MX-3005 real-time PCR equipment
(Stratagene, Cedar Creek, USA), using 2 ml (20 ng) of cDNA
template, 1 nmol of primers, and 12.5 ml of iQ SYBR green
supermix (Bio-Rad, Hercules, CA) in a total volume of 25 ml
reaction. The primers used for the quantitative PCR are shown in
Table 1. The cDNA were amplified with initial denaturation at
95uC for 10 min, followed PCR by 40 cycles of: 95uC3 0s ,6 0 uC
30 s, 72uC 40 s and finally 1 cycle of melting curve following
cooling at 40uC for 10 s. To confirm amplification specificity the
PCR products from each primer pair were subjected to a melting
curve analysis. Analysis of relative gene expression was done by
evaluating q-RT-PCR data by 2
(-DDCt) method as described by
others [35,36]. Each experiment was repeated at least three times
and GAPDH or 18S was used as housekeeping gene for internal
control. The changes observed as a result of H2O2 stimulation
were expressed as fold change while the changes observed as a
result of Tb4 treatment were depicted as percent increase or
decrease unless otherwise noted.
RNA interference and siRNA transfection
Silencing of Cu/Zn-SOD, catalase and Bcl2 proteins was
achieved by using small interfering RNA (si-RNA) transfections.
Pre-designed double-stranded si-RNA against Cu/Zn-SOD (SA-
SI_Rn01_00112871), catalase (SASI_Rn01_00053417) and Bcl2
(SASI_Rn01_00062026) were purchased from Sigma Life Science
(Saint Louis, MO, USA). As a negative control, non-targeting
control si-RNA (scrambled si-RNA), verified to have no significant
effect on most essential mammalian genes, was obtained from
Sigma. Rat neonatal fibroblasts were seeded into 6-well plates with
3 mL of complete DMEM. After 24 h, the medium was replaced
with 2 mL of Opti-MEM (Life Technologies). Cells were then
transfected with 200 pmol of the siRNAs for catalase, Cu/Zn-
SOD, Bcl2 or negative control siRNA using N-TER
TM nanopar-
ticle siRNA transfection system (Sigma) as per the manufacturer’s
protocol. After 24 h of transfection, cells were treated and
harvested to determine the transfection efficiency and effect of
Tb4 in presence and absence of H2O2 treatment. Quantification
of caspase-3 gene expression by q-RT- PCR was done to study the
extent of pro-apoptotic gene expression.
TUNEL staining
Quantification of TUNEL staining was done to study the extent
of apoptotic cell death on transfected fibroblasts by in situ cell death
detection kit (Roche Applied Science, Indianapolis, IN). Briefly,
2610
5 fibroblasts were seed on the coverslips in the 6-well plates,
followed by siRNA transfections and treatment. The TUNEL
staining was done using deoxyneucleotidyl transferase (TdT) and
FITC-labeled 29-deoxyuridine 59-triphosphate (dUTP) as per
manufacturer’s instructions. The Analysis was done using 3–5
images from hi-power field (40X objective) and the TUNEL index
(%) was calculated as the number of TUNEL-positive cells divided
by the total number of DAPI-stained nuclei.
Statistical analyses
All experiments were performed at least three times for each
determination. Data are expressed as means6Standard Error (SE)
and were analyzed using student t-test or one-way analysis of
variance (ANOVA) and secondary analysis for significance with
Tukey–Kramer post tests using Prism 5.0 Graph Pad software
(Graph Pad, San Diego, CA, USA). A p value less than 0.05 was
considered statistically significant.
Results
Pretreatment with Tb4 improves cardiac fibroblasts
survival
The viability of cardiac fibroblasts cells was assessed after
treating the cells with various concentrations of H2O2 for 24 h by
MTT assay. We observed that the 50% lethal dose (LD50)o fH 2O2
on these cells was between 150 and 250 mM (Figure 1A).
Pretreatment with Tb4( 1mg/mL) resulted in an improved cell
survival count (19.2%; p,0.05) compared to the untreated group.
This beneficial effect of pretreatment was observed until 100 uM
Table 1. List of quantitative real-time PCR used in the study.
Gene Forward Primer Reverse Primer
CTGF ACTATGATGCGAGCCAACTGC TGTCCGGATGCACTTTTTGC
Collagen 1 TGGCCTTGGAGGAAACTTTG CTTGGAAACCTTGTGGACCAG
Fibronectin TGCAGTGACCAACATTGATCGC AAAAGCTCCCGGATTCCATCC
Mn-SOD TGGACAAACCTGAGCCCTAA GACCCAAAGTCACGCTTGATA
Cu/Zn-SOD TGGGAGAGCTTGTCAGGTG CACCAGTAGCAGGTTGCAGA
Catalase ATCAGGGATGCCATGTTGTT GGGTCCTTCAGGTGAGTTTG
Bcl2 GTACCTGAACCGGCATCTG GGGGCCATATAGTTCCACAA
BAX CGAGCTGATCAGAACCATCA GGGGTCCCGAAGTAGGAA
GAPDH CCAGGTGGTTCCTCTGACTTC GTGGTCGTTGAGGGCAATG
18S TGTTCACCATGAGGCTGAGATC TGGTTGCCTGGGAAAATCC
doi:10.1371/journal.pone.0026912.t001
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was compromised. This indicated a potential role of Tb4i n
protecting the cardiac fibroblasts against cell death due to
generation of ROS. The optimal concentration of H2O2 was
determined from MTT experiment and thus standardized dose of
100 mMH 2O2 which was used throughout the study.
Tb4 protects cardiac fibroblasts against H2O2 induced
oxidative stress
Oxidative stress leads to detrimental changes in the cell
signaling process. To determine whether Tb4 has any effect on
ROS activity under oxidative stress, intracellular ROS levels in
the cardiac fibroblast were estimated after H2O2 treatment by
confocal microscopy and fluorimetry. Cardiac fibroblasts
treated with H2O2 showed enhancement of fluorescence
intensity of DCF-DA by 9.9-fold at 12 h (p,0.01) and 13.8-
fold at 24 h (p,0.01), respectively, compared to the untreated
controls (Figure 1B). Pretreatment with Tb4 showed a 50.2%
decrease at 12 h (p,0.05) and 75.1% at 24 h (p,0.05),
respectively, compared to H2O2 treated cardiac fibroblasts.
Tb4 treatment reduced the DCF-DA fluorescence by 32.2%
(p,0.01) in the unstimulated cardiac fibroblast indicating that
Tb4 treatment was effective in preventing oxidative stress in
cardiac fibroblasts. The confocal microscopy images matched
with the quantitative fluorimetry results (Figure 1C). Our data
indicated that Tb4 abrogated the ROS activity significantly in
cardiac fibroblasts.
Tb4 reduces the formation of superoxide radicals and
nitric oxide
Oxidative stress generated superoxide and nitric oxide radicals.
These can lead to production of more noxious free radicals, like
peroxynitrite (ONOO
-). To evaluate the effect of Tb4i n
superoxide and nitric oxide radical generation in cardiac
fibroblasts, we estimated the levels of those free radical generations
from H2O2 treatment by using confocal microscopy. The confocal
microscopy data showed that H2O2 treated cells enhanced the
fluorescence intensity of DHE and DAF-2DA, an indicator of
increased O2
.- and NO radicals, compared to the controls
(Figure 1D and E). The enhanced fluorescence intensity of DHE
and DAF-2A was prevented by Tb4 pretreatment, compared to
the H2O2 treated cells (Figure 1 D and E). The quantifications of
image intensities were tabulated in Table 2. Together, our data
suggest that Tb4 attenuated H2O2 induced superoxide and nitric
oxide radical generation in cardiac fibroblasts.
Tb4 treatment prevents the loss of mitochondrial
membrane potential (Dym)
Oxidative stress impacts the mitochondrial function leading
to disruption of electron transport and loss of mitochondrial
transmembrane potential. We evaluated the effect of Tb4o nt h e
mitochondrial membrane potential in the cardiac fibroblast
under H2O2 induced oxidative stress using MitoTrackerH Red
by confocal microscopy. Our data showed that there was loss of
Dym as indicated by a decrease in thef l u o r e s c e n c ei n t e n s i t yo f
MitoTrackerH Red in H2O2-treated cells. This decrease in the
fluorescence intensity was prevented by the pretreatment with
Tb4( F i g u r e1F )s u g g e s t i n gt h a tT b4 protected mitochondrial
function by preventing the loss of Dym in the cardiac fibroblast.
The quantifications of image intensities were tabulated in
Table 2. Our data suggest that Tb4 treatment significantly
reduced mitochondrial potential in H2O2 treated cardiac
fibroblasts.
Figure 1. Effect of Tb4 on cell viability in H2O2 treated
fibroblasts. (A) The MTT assay was performed with increasing H2O2
concentration (1 to 250 mM) in presence (dotted lines) and absence
(solid lines) of Tb4( 1 mg/mL). Data represent means6SEM of 3
individual experiments. (B) Representative confocal laser scanning
microscopy images of cardiac fibroblasts stained with DCF-DA showing
the effect of Tb4 on intracellular ROS upon treatment with H2O2.( C).
Effect of Tb4 on generation of ROS in fibroblasts treated with H2O2 by
fluorimetry. The graph represents the percentage of fluorescence
positive fibroblasts upon staining with DCF-DA. Data represent the
mean6SE of at least three separate experiments. * means p,0.05
compared to the controls and # represents p,0.05 compared to the
respective H2O2 treated group (D) Representative confocal laser
scanning microscopy images of cells stained with DHE Red showing
the effect of Tb4 on generation of superoxide radicals upon treatment
with H2O2 in fibroblast. (E). Representative confocal laser scanning
microscopy images of cells stained with DAF-2DA showing the effect of
Tb4 on generation of nitric oxide upon treatment with H2O2 in
fibroblast. (F). Representative confocal laser scanning microscopy
images of cells stained with Mitotracker Red showing the effect of
Tb4 on loss of mitochondrial membrane potential upon treatment with
H2O2 in fibroblast.
doi:10.1371/journal.pone.0026912.g001
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genes in cardiac fibroblasts under oxidative stress
We examined the effect of Tb4 on mRNA expression of
antioxidant genes like Mn-SOD, Cu/Zn-SOD and catalase in
cardiac fibroblasts under oxidative stress by q-RT- PCR. Our
data showed that there was an increase in the expression of Mn-
SOD in the H2O2-treated cells by 2.7-fold and 1.3-fold increase
at 12 and 24 h, respectively, compared to the untreated cells.
Tb4 treatment did not alter the mRNA expression of Mn-SOD at
these time points, compared to the H2O2-treated groups
(Figure 2A). H2O2 treatment reduced the mRNA expression of
Cu/Zn-SOD by 95% at 12 h (p,0.05) and 98% at 24 h
(p,0.05), respectively, compared to the untreated cells. Treat-
ment with Tb4 resulted in an increase of expression of Cu/Zn-
SOD. Tb4 pretreatment restored the Cu/Zn-SOD mRNA
expression back to normal levels both at 12 h and 24 h,
respectively, compared to the H2O2 treated cells (Figure 2B). In
unstimulated cell, the mRNA expression of catalase was
upregulated by 1.3-fold after Tb4 treatment. H2O2 treatment
reduces the catalase mRNA expression by 50% (p,0.05) and
89% (p,0.05) at 12 and 24 h treatment, respectively, compared
to the control. Pretreatment with Tb4 upregulated the catalase
mRNA expression by 1.5-fold (p,0.05), and 6.4-fold (p,0.05) at
12 h and 24 h, respectively, compared to the H2O2 treated cells
(Figure 2C).
To examine the status of the above antioxidant genes at the
translational levels, western blots were performed. Our data
showed that the expression level of Mn-SOD was relatively
unchanged at protein level at 12 h and 24 h, respectively.
Treatment with Tb4 did not alter the expression of Mn-SOD
(Figure 2D). Compared to the untreated cells, H2O2 treatment
showed a decline of Cu/Zn-SOD protein expression by 23%
(p,0.05) and 24.6% (p,0.05) at 12 h and 24 h, respectively,
compared to the controls. Cells pretreated with Tb4 showed a
2.0-fold (p,0.05) and 1.4-fold (p,0.05) increased in the
expression of Cu/Zn-SOD at 12 h and 24 h treatment,
respectively, compared to the H2O2 treated cells (Figure 2D).
The expression of catalase declined by 25% (p,0.05) at 12 h and
15% (p,0.05) at 24 h, respectively, with H2O2 treatment
compared to untreated cells. Tb4 pretreatment increased catalase
expression by 1.3-fold (p,0.05) and 1.4-fold (p,0.05) increase at
12 h and 24 h, respectively, compared to the H2O2 treated cells
(Figure 2D). The normalized quantification for Mn-SOD, Cu/
Zn-SOD and catalase expression by densitometry is shown in the
Figure 2E.
Tb4 promotes cell survival by increasing the expression
of anti-apoptotic genes and reducing the expression pro-
apoptotic genes in cardiac fibroblasts under oxidative
stress
To examine the effect of Tb4o nc a r d i a cd e a t ha n ds u r v i v a l ,w e
determine the expression of caspase-3, Bax (pro-apoptotic) and Bcl2
(anti-apoptotic) in presence and absence of H2O2 by qRT-PCR.
H2O2 treatment upregulated the caspase-3 expression by 3.0-fold
(p,0.05) and 5.0-fold (p,0.05) at 12 h and 24 h treatment,
respectively, compared to the untreated cells. Tb4 pretreatment
resulted in 29% (p,0.05) and 19% (p,0.05) decrease in the mRNA
expression of caspase-3 at 12 h and 24 h treatment, compared to
H2O2 treated cells (Figure 3A). H2O2 treatment increased mRNA
expression of Bax by 1.6-fold (p,0.05) and 2.1-fold (p,0.05) at 12 h
and 24 h, respectively, compared to untreated cells. The mRNA
expression of Bax was reduced by 31% (p,0.05) and 26% (p,0.05)
at 12 h and 24 h, respectively with pretreatment Tb4 treatment
(Figure 3B). The mRNA expression of Bcl2 concomitantly decreased
by 11% (p,0.05) and 23% (p,0.05) at 12 h and 24 h, respectively in
H2O2 treatment. The mRNA levels of Bcl2 was increased by
pretreatment with Tb4 by 20% (p,0.05) and 14% (p,0.05) at 12 h
and 24 h, respectively, compared to H2O2-treated cells (Figure 3 C).
At translational level, H2O2 treatment resulted in a 2.8-fold
(p,0.05) and 2.6-fold (p,0.05) increase in the expression of caspase-3
protein at 12 h and 24 h period, respectively, compared to the
untreated cells. Tb4 pretreatment showed 39% (p,0.05) and 9%
(p=ns) decrease in the caspase-3 expression at the above time point,
compared to H2O2-treated cells. (Figure 3 D). GAPDH was used as
internal loading control. The normalized quantification of caspase-3
b yw e s t e r nb l o t t i n gi ss h o w ni nt h eF i g u r e3 E .H 2O2 treatment
showed an increase in the Bax/Bcl2 ratio by 1.8-fold (p,0.05) and
2.3-fold (p,0.05) at 12 h and 24 h, respectively, compared to the
controls. Tb4 treatment significantly prevented this increase in the
Bax/Bcl2 ratio by 31% (p,0.05) and 43% (p,0.05) at 12 h and 24 h,
respectively, compared to H2O2-treated cells (Figure 3 E).
Tb4 reduced the expression of pro-fibrotic genes in
cardiac fibroblast under oxidative stress
We next determine the pro-fibrotic gene expression under
oxidative stress condition. Our data showed that H2O2 treatment
increased the mRNA expression of CTGF by 2.3-fold (p,0.05) and
2.3-fold (p,0.05) at 12 h and 24 h, respectively, compared to the
controls. Tb4 treatment showed reduction in the mRNA expression
of CTGF by 17% (p,0.05) and 38% (p,0.05) at 12 h and 24 h,
respectively (Figure 4 A). The mRNA expression of collagen-1 was
increased by 4.0-fold (p,0.05) and 5.7-fold (p,0.05) at 12 h and
24 h, respectively, in H2O2-treated cells compared to the controls.
Tb4 pretreatment decreased collagen-I by 46% (p,0.05) and 42%
(p,0.05) at 12 h and 24 h, respectively, compared to the H2O2-
treated cells (Figure 4 B). The mRNA expression of fibronectin was
increased by 2.1-fold (p,0.05) and 3.3-fold (p,0.05) at 12 h and
24 h,respectively,inthe H2O2-treatedcells.The mRNAexpression
of fibronectin in the Tb4 treatment was decreased by 9% (p=ns)
and 34% (p,0.05) at 12 h and 24 h, respectively, compared to the
H2O2-treated cells (Figure 4C).
At translational level, we did not observe any significant change
in the CTGF protein level under oxidative stress. However,
pretreatment with Tb4 reduced the expression of CTGF by 27%
(p,0.05) and 43% (p,0.05) at 12 h and 24 h, respectively,
compared to the H2O2 treated cells. The collagen-I protein
expression also increased in H2O2 treatment by 24% (p,0.05) and
21% (p,0.05) at 12 h and 24 h treatment, respectively, compared
to the controls. Tb4 treatment reduced collagen-I protein
Table 2. Image intensities (Arbitrary Units) showing the
fluorescence intensities in cardiac fibroblasts upon staining
with DCF-DA, DHE, DAF-2DA and MitoTracker Red.
S. No. Staining Control Tb4H 2O2 H2O2 + Tb4
1 DCF-DA (H2O2) 2596 48 96619* 614626* 183641
#
2 DHE (O2
- radicals) 428652 461681 892662* 659635
#
3 DAF-2DA (NO) 305643 274643 948647* 308641
#
4 MitoTracker Red (Dym) 644658 657673 253645* 618638
#
Data acquired from at least 15 fields taken from 3–4 different confocal images
of the same treatment group and were quantified by using ImageJ Software.
*denotes p,0.05 compared to controls while.
#denotes p,0.05, compared to the H2O2-treated group.
doi:10.1371/journal.pone.0026912.t002
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24 h, respectively, compared to the H2O2 treated cells. The
collagen-III protein expression also increased in H2O2 treatment
by 14% (p,0.05) and 30% (p,0.05) at 12 h and 24 h,
respectively, compared to controls. Tb4 treatment reduced the
collagen-III expression by 7% (p=ns) and 16% (p,0.05) at 12 h
and 24 h, respectively, compared to the H2O2 treated cells
(Figure 4 D). The normalized quantification of each western blot
profile is shown (Figure 4 E).
Effect of knocking down of Cu/Zn-SOD, catalase and Bcl2
in cardiac fibroblasts
We first determine the efficacy of siRNA mediated transfection
of Cu/Zn-SOD, catalase and Bcl2 in cardiac fibroblasts. Western
blots were performed to confirm the specific knock-down of Cu/
Zn-SOD, catalase and Bcl2 in cardiac fibroblasts.
To determine whether Tb4 has target for Cu/Zn-SOD,
catalase and Bcl2, we tested the effect of Tb4 in the cardiac
fibroblasts either transfected with scrambled siRNA or siRNA of
catalase, Cu/Zn-SOD, and Bcl2 in the presence and absence of
H2O2 induced oxidative stress. Treatment with scrambled siRNA
did not alter the expression of catalase, Cu/Zn-SOD, and Bcl2;
therefore, scrambled siRNA treated group was taken as control for
this experiment. Cardiac fibroblasts transfected only with
scrambled siRNA showed 15.565.4%, 12.666.4% and
18.160.9% (p,0.05) increased protein expression of catalase,
Cu/Zn-SOD and Bcl2, due to Tb4 treatment (Fig 5 B, D and E,
2
nd lane). H2O2 treatment under non-silencing (scramble treated)
Figure 2. Effect of Tb4 on antioxidant genes under oxidative stress in cardiac fibroblasts. Cells were treated with H2O2 in presence and
absence of Tb4 and (A) Mn-SOD, (B) Cu/Zn-SOD and (C) catalase, mRNA expression were analyzed at 12 h and 24 h, respectively by qRT-PCR. Data
represent the means6SE of at least three separate experiments. (D) Western blot analysis showed the protein expression of Mn-SOD, Cu/Zn-SOD and
catalase at 12 h and 24 h, respectively. GAPDH was used as internal loading control for the experiment. (E) Graph shows the relative fold change in
the protein expression of Mn-SOD, Cu/Zn-SOD and catalase, respectively by densitometry. Data represent means6SEM from 3 individual
experiments. * denotes p,0.05, compared to controls while
# denotes p,0.05, compared to the H2O2-treated group.
doi:10.1371/journal.pone.0026912.g002
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(p,0.05) down regulation of catalase, Cu/Zn-SOD, and Bcl2,
respectively, compared to the control (Fig 5 B, D and E, 3
rd lane
vs. 1
st Lane). In the scramble treated condition, Tb4 pre-treatment
resulted in significant upregulation of catalase, Cu/Zn-SOD, and
Bcl2 (44.663.2%, 145.6611.2%, 62.165.7%; respectively,
p,0.05), compared to H2O2 treated cardiac fibroblasts (Fig 5 B,
D and E, 4
th lane).
In comparison to the scrambled siRNA treated set (Fig 5B, D
and F, 1
st lane), our data showed 64.263.1% (p,0.05) knock-
down of catalase, 77.162.9% (p,0.05) knock-down of Cu/Zn-
SOD and 61.263.9% (p,0.05) knock-down of Bcl2, when their
specific siRNAs were transfected into the fibroblasts (Figure 5A, C
and E, 1
st lane).
The down regulation in the levels of catalase, Cu/Zn-SOD and
Bcl2 proteins was abrogated by pre-treatment of Tb4 (Fig 5 A, C
and E, 2
nd lane). We observed that the expression of catalase, Cu/
Zn-SOD, and Bcl2 was upregulated by 84.565.4%, 45.6611.2%,
39.866.4%, respectively, p,0.05, compared to their control
group (Fig 5 A, C and E, 1
st lane). Furthermore, to evaluate the
effect of Tb4 under more stringent conditions, the siRNA-treated
fibroblasts were subjected to H2O2 challenge, to further enhance
the levels of oxidative stress. Our data showed that H2O2
treatment further depleted the levels of catalase, Cu/Zn-SOD
and Bcl2 (Figure 5A, C, E (3
rd Lane). This dual stress ultimately
reduced the expression of catalase, Cu/Zn-SOD and Bcl2 to
23.363.8%, 17.264.1% and 12.762.1% (p,0.05) of the
endogenous levels (Figure 5A, C, E; 3
rd Lane). Tb4 pretreatment
resulted in a significant upregulation of catalase and Cu/Zn-SOD
(142.467.3% and 36.564.1%, respectively, p ,0.05) but not for
Bcl2 (12.568.1%, p.0.05), compared to respective controls
(Figure 5A, C, E (4
th Lane). This implicates that under conditions
Tb4 restored the levels of catalase and Cu/Zn-SOD but failed to
restore the expression of Bcl2. GAPDH was used as an internal
Figure 3. Effect of Tb4 on pro- and anti-apoptotic genes under oxidative stress in cardiac fibroblasts. Cells were treated with H2O2 in the
presence and absence of Tb4 and (A) Caspase-3, (B) Bax and (C) Bcl2 mRNA expression were analyzed at 12 h and 24 h, respectively by qRT-PCR. Data
represent the means6SEM of at least three separate experiments. (D) Protein expression of Caspase-3, Bax and Bcl2 at 12 h and 24 h, respectively.
GAPDH was used as loading control for the experiment. (E) GAPDH was used as internal loading control for the experiment. (E) Graph shows the
relative fold change in the protein expression of Bax, Bcl2 and caspase-3, respectively by densitometry. Data represent means6SEM from 3 individual
experiments. * denotes p,0.05 compared to controls while
# denotes p,0.05, compared to the H2O2-treated group and
@ means p=ns compared,
to the H2O2-treated group.
doi:10.1371/journal.pone.0026912.g003
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down of catalase, Cu/Zn-SOD and Bcl2 protein and the
restoration of their expression upon Tb4 treatment is shown in
Fig 5 I.
To test the effect of Tb4 on induction of apoptosis, we further
determined the expression of caspase-3, under the similar
condition stated above. In scramble transfected cells, the
expression of caspase-3 increased to 3.8-fold (p,0.05) in H2O2
treatment, which reduced by 26% (p,0.05) upon pretreatment
with Tb4 (Figure 5 J). In Bcl2 knocked down cells, the expression
of caspase-3 increased by 1.7-fold (p,0.05), compared to the
scrambled siRNA-transfected cells. H2O2 treatment potentiate a
6.0-fold (p,0.05) increase of caspase-3, suggesting an additive
effect. Tb4 treatment resulted in an 18% reduction (p,0.05) in the
expression of caspase-3, compared to H2O2 stimulated cells
(Figure 5J, second group). Similarly, knockdown of catalase gene
resulted an increase of 2.1-fold (p,0.05) caspase-3 expression.
H2O2 treatment showed an additive effect by increasing a 5.7-fold
(p,0.05) of caspase-3. Tb4 pretreatment resulted in a 25%
(p,0.05) reduction in the caspase-3 activity in the H2O2
stimulated cells (Figure 5J, third group), compared to the H2O2-
treated group. The expression of caspase-3 also increased by 1.5-
fold (p,0.05) when Cu/Zn-SOD was knocked down in fibro-
blasts. H2O2 treatment under similar condition resulted in 4.1fold
(p,0.05) increase of caspase-3 and Tb4 pretreatment attenuated
the caspase-3 activity by 18% (p,0.05), compared to H2O2
treated cells (Figure 5J, fourth group).
Finally, we performed TUNEL assay under the similar
experimental conditions. Our data showed an increase of TUNEL
positive nuclei in H2O2 treated cells as well as knockdown of
catalase, Cu/Zn-SOD, and Bcl2. Representative of fluorescence
microscopy images of TUNEL positive nuclei (FITC-positive) are
shown in Figure 6 A and B. Transfection with scrambled si-RNAs
followed by H2O2 treatment showed an increase of TUNEL
positive nuclei from 3.760.3 to 18.260.4. Furthermore, knock-
down of catalase, Cu/Zn-SOD and Bcl2 resulted in a significant
Figure 4. Effect of Tb4 on profibrotic genes under oxidative stress in cardiac fibroblasts. Cells were treated with H2O2 in the presence and
absence of Tb4 and (A) CTGF, (B) Col-I and (C) Fibronectin mRNA expression was analyzed at 12 h and 24 h, respectively by qRT-PCR. Data represent
the means6SE of three separate experiments. (D) Western blot analysis showed the protein expression of CTGF, Col-I and Col-III at 12 h and 24 h,
respectively. GAPDH was used as a loading control for the experiment. (E) Graph shows the relative fold change in the protein expression of Bax, Bcl2
and caspase-3, respectively by densitometry. Data represent means6SEM from 3 individual experiments. * denotes p,0.05, compared to controls
while
# denotes p,0.05 compared to the H2O2-treated group and ø denotes p.0.05, compared to controls.
doi:10.1371/journal.pone.0026912.g004
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24.063.6% (p,0.05) and 30.760.9% (p,0.05), respectively
(Figure 6 C), compared with the control cells. H2O2 treatment in
the similar experimental set up (knocked down cells), resulted an
additive effect and increased the TUNEL positive nuclei to
50.765.9% (p,0.05) for catalase, 46.366.6% (p,0.05) for Cu/
Zn-SOD, and 58.7610.4% (p,0.05) for Bcl2, respectively,
compared to the scramble si-RNA (23.261.9%). Pretreatment with
Tb4i nt h eH 2O2 treated group resulted in a significant reduction in
the TUNEL-positive nuclei to 18.062.1% (p,0.05) in si-RNA-
catalase, 18.762.0% (p,0.05) in si-RNA Cu/Zn-SOD, and
31.367.8% (p,0.05) in si-RNA Bcl2, respectively (Figure 6 C).
These results indicate that Tb4 selectively targets antioxidant and
anti-apoptotic genes to provide protection under oxidative stress.
Discussion
The current study was aimed to determine the target molecules
modulated by Tb4 that enables it to prevent oxidative stress in an
in vitro system using cardiac fibroblasts. H2O2 induced a marked
increase in intracellular ROS in the cardiac fibroblasts. This
increase in the intracellular ROS led to altered expression of
antioxidant enzymes like the SODs and catalase. Increased ROS
also led to the loss of mitochondrial membrane potential and
subsequently an increase in the Bax/Bcl2 ratio favoring apoptosis.
This study shows for the first time that Tb4 reduced the ROS
accumulation by modulating the expression of antioxidant
enzymes especially catalase and Cu/Zn-SOD and thereby
preventing the loss of mitochondrial membrane potential.
Figure 5. Effect of Tb4 on antioxidant and antiapoptotic genes under siRNA knock down of catalase, Cu/Zn-SOD and Bcl2 genes in
cardiac fibroblasts under normal and oxidative stress condition. Representative western blot illustrating the restoration of the expression of
catalase, Cu/Zn-SOD and Bcl2 in the cardiac fibroblasts upon knockdown of antioxidant and antiapoptotic genes, viz., (A) siRNA-catalase vs.( B)
scrambled siRNA; (C) siRNA-Cu/Zn-SOD vs.( D) scrambled siRNA and (E) siRNA-Bcl2 vs.( F) scrambled siRNA, respectively. (G and H) GAPDH was used
as an internal loading control for the above experiments. (I) Effect of Tb4 on antioxidant and antiapoptotic genes under control and siRNA knock
down of catalase, Cu/Zn-SOD and Bcl2 genes in cardiac fibroblasts under normal and oxidative stress condition. Data represent the means6SE of at
least three separate experiments. Clear bars represent the normalized protein expression of respective proteins in the si-scrambled RNA condition
while the color bars represent the normalized protein expression under the respective siRNA knockdown conditions. * denotes p,0.05, compared to
si-scramble control,
# denotes p,0.05, compared to si-scramble and H2O2 treated group, ** denotes p,0.05, compared to si-RNA control group and
## denotes p,0.05, compared to the respective si-RNA and H2O2 treated group while
@ denotes p=ns, compared to si-RNA and H2O2 treated group.
(J) Bar graph shows relative fold-change in the mRNA expression of caspase-3 in Tb4 pretreated cardiac fibroblasts under respective siRNA
knockdown and H2O2 induced oxidative stress. Data represent the means6SE of at least three separate experiments. * denotes p,0.05, compared to
controls while
# denotes p,0.05 compared to the H2O2-treated group.
doi:10.1371/journal.pone.0026912.g005
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protein Bcl2 and prevented apoptosis of cardiac fibroblasts in
response to oxidative stress. Tb4 failed to alleviate the oxidative
stress and prevent cardiac apoptosis when these molecules were
knocked down in the cells. Thus, Tb4 possibly targets antioxidant
and anti-apoptotic genes to provide protection under oxidative
stress in cardiac fibroblasts.
The myocardium is composed of cardiomyocytes, fibroblasts,
endothelial cells and other cell types along with surrounding
extracellular matrix (ECM). Apart from the myocytes, cardiac
fibroblasts make up the bulk of the myocardium and important
cell type as they can play crucial role in cardiac protection by
providing sustenance, ECM support and defense against
various stress conditions. Therefore, in this study, we used
cardiac fibroblasts, so as to study the effect of Tb4o nt h i sc e l l
type and to study how oxidative stress affects them in the in vitro
system.
In the cardiac cells, H2O2 is known to induce oxidative stress
and apoptosis. This system has been used on various occasions as a
model to study the regulation of stress signaling stimuli in cell
death [37,38]. Here, we used this model system to show the effects
of Tb4o nH 2O2 induced fibroblast cell death. Our results indicate
that 2 h pretreatment with Tb4 is able to significantly decrease the
apoptotic effects of H2O2 in cardiac fibroblasts and thus protecting
Figure 6. Effect of Tb4 on cardiac fibroblast apoptosis under oxidative stress. (A) Representative fluorescent microscopy images of TUNEL
staining in rat neonatal cardiac fibroblasts. Bright TUNEL-positive staining (FITC) was observed in H2O2 treatment which was not observed in control
cells and cells pretreated with Tb4. DAPI was used to stain the intact nuclei and counterstaining of filamentous actin was done with Texas RedH-X
phalloidin. (B) Representative fluorescent microscopy images showing the effect of Tb4 treatment in presence and absence H2O2-induced oxidative
stress on cardiac fibroblasts transfected with siRNAs of Cu/Zn-SOD, catalase and Bcl2 vs. scrambled siRNA, respectively. (C) Bar graph shows the
percent TUNEL-positive nuclei under similar experimental condition. Data represent the means6SE of at least three separate experiments. A total of
65 to 82 nuclei were counted for each observation. * denotes p,0.05 compared to controls while
# denotes p,0.05, compared to the H2O2-treated
group.
doi:10.1371/journal.pone.0026912.g006
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biochemical effects stimulated by Tb4 treatment play a crucial role
in the cardio-protection under oxidative stress. H2O2 treatment on
cardiac fibroblasts leads to increase ROS accumulation especially
O2
.-,H 2O2 or OH
-. Superoxide dismutase (SOD) converts O2
.-
into H2O2 and the latter can generate hydroxyl (OH
-) radicals in
the presence of Fe
2+ cations. ROS are able to oxidize biological
macromolecules such as DNA, protein and lipids [39,40,41]. Also,
NO can also be oxidized into reactive nitric oxide species, which
may show behavior similar to that of ROS. In particular, the
combination of NO and O2
.- can yield a strong biological oxidant,
peroxynitrite that is more detrimental to the cells [42]. Oxidative
stress causes altered expression of antioxidant enzymes SOD and
catalase which prevents effective scavenging of the ROS formed as
a result of H2O2 treatment in the fibroblasts. Our results show that
Tb4 restored the levels of Cu/Zn-SOD and catalase close to
normal physiological level even under oxidative stress and thus
scavenging the extra H2O2-induced ROS from the cellular system.
One of the traditional hallmarks of ROS initiated cell death is
mitochondrial dysfunction and energy depletion [43]. This is
manifested by opening of the mitochondrial permeability transi-
tion pore (MPTP), the collapse of the mitochondrial membrane
potential (Dym) and a concomitant drop in ATP production [44].
These events lead to cascade of cell destruction and apoptosis.
Increased production of ROS in the failing heart leads to
mitochondrial permeability transition [45], which causes loss of
mitochondrial membrane potential, swelling of mitochondrial
matrix, release of apoptotic signaling molecules, such as
cytochrome c, from the inter-membrane space, and irreversible
injury to the mitochondria [46]. Increased ROS in our system led
to a decrease in the Dym as evident by the staining with
MitoTracker Red. This loss of Dym was prevented by
pretreatment of Tb4. At this point, it is beyond our scope to
investigate how Tb4 modulate mitochondrial membrane potential
under oxidative stress and, therefore, warranted further investiga-
tion.
Tb4 was extremely effective in reducing intracellular ROS in
H2O2 treated cardiac fibroblasts (Figure 2 A-C). Tb4 acts via
upregulation of selected antioxidant genes like Cu/Zn-SOD and
catalase. In fact, the intracellular ROS level was markedly reduced
when the cells were pretreated with Tb4 at least 2 h prior to H2O2
exposure, suggesting that it might activate the key molecules that
play an important role in the enzymatic antioxidant defense
system. Another particularly relevant protein that loses function
upon oxidation is Mn-SOD; its loss of function would further
compromise antioxidant capacity and lead to further oxidative
stress [47]. Both Mn-SOD and Cu/Zn-SOD have been reported
to play a crucial role in protecting the cardiac cells from oxidative
damage by scavenging ROS [48]. In our experimental system, we
found that Tb4 upregulated the expression levels of Cu/Zn-SOD
and not Mn-SOD in cardiac fibroblast thus affording cardiac
protection which is in contrast to the previous report by Ho et al
[23]. This could be probably due to the different cell type used in
the study. Catalase, which was directly responsible for H2O2
clearance, was upregulated by Tb4 both at protein and gene level
in the presence of H2O2, indicating that Tb4 preferentially targets
catalase which enables effecting scavenging of the H2O2 from the
system. The mechanism of Cu/Zn-SOD and catalase upregula-
tion by Tb4 is currently unknown but, a transcription factor
mediator activity has been postulated [49]. Tb4 has been reported
to translocate into the nucleus by an active transport mechanism
or possibly through its cluster of positively charged amino acid
residues (KSKLKK) but the exact function is still obscure.
Alternatively, it might be the similar event like nuclear localization
of actin where it is postulated that it might involve in chromatin
remodeling [50], mRNA processing and transport [51].
Improved fibroblast survival during oxidative stress is important
because increased fibroblast survival belittles the cardiac injury
and prevents overall damage to the heart. Oxidative stress is
known to trigger apoptotic cell death by up regulating the
expression of pro-apoptotic protein like Bax which then dimerises
and translocate to the outer mitochondrial membrane and
aggregates to form pores that permit cytochrome c from
mitochondria to cytosol [52]. Oxidative stress also leads to
activation of caspase-3 cleavage and initiation of intrinsic
apoptotic pathway [52]. Therefore, reduction in the production
and accumulation of intracellular ROS is important to protect the
cells from apoptosis triggered by the intrinsic pathway. Our data
further showed that Tb4 treatment inhibits excessive Bax
expression and caspase-3 activation and enhance Bcl2 expression
in fibroblast suggesting its protective effects under oxidative stress.
As Tb4 reduces the intracellular ROS levels, it would be
reasonable to explain that Tb4 probably promote the Bcl2/Bax
ratio to protect the cells from apoptosis. To best of our knowledge,
this is the first report that elucidates the beneficial effect of Tb4i n
cardiac fibroblast by up regulating the Bcl2/Bax ratio in favor of
cell survival. This finding is in contrast to the previous report by
Sosne et al, where they did not observe any change in the Bax/
Bcl2 expression [18]. This could be probably due to the different
cell type used in the study. Although, there is no definitive
mechanism by which Tb4 exerts this anti-apoptotic effects, but, an
internalization of Tb4 has been proposed as one of the possible
mechanism in human corneal epithelial cell under oxidative stress
[19]. Alternatively, Tb4 may use its methionine residues to react
with intracellular oxygen at the post-translational level to generate
sulfoxide, reducing the ROS level and eventually protects the cells
from apoptosis [53].
Increased oxidative stress leads to pro-fibrotic changes in the
fibroblasts [54,55]. We observed that there was an increase in the
expression of pro-fibrotic genes like CTGF, Collagen-I, Collgen-
III and fibronectin in cardiac fibroblasts treated with H2O2.
Decreased expression of fibrotic genes in the fibroblasts is
beneficial because it prevents cardiac fibrosis and stiffening by
reducing the ECM deposition. Our study showed that the increase
in the pro-fibrotic gene expression was prevented by pretreatment
of fibroblasts with Tb4. These results corroborated with our
previous observation in myocardial infarction (MI) model [22]. We
showed that Tb4 abrogated cardiac fibrosis in post-MI period by
attenuating collagen type I and type III gene expression. This is
the first report that elucidates the down regulation of pro-fibrotic
gene expression by Tb4 under oxidative stress.
Interestingly, we found that Tb4 prevented apoptotic cell death
by specifically targeting these antioxidant and anti-apoptotic
molecules and when these antioxidant and apoptotic molecules
were knocked down by si-RNA treatment; Tb4 was not able to
contribute its cardio-protective effects. These findings led us to
suggest that Tb4 provide cardiac protection by reducing the
intracellular ROS levels and enhancing the expression of
antioxidant enzymes (Cu/Zn-SOD and catalase) and anti-
apoptotic protein (Bcl2) under oxidative stress.
In conclusion, we demonstrated that Tb4 protects the cardiac
fibroblasts against apoptosis by reducing intracellular oxidative
stress through enhancing the expression of selected anti-oxidative
enzymes and anti-apoptotic proteins. Given the preference of
cardio-protective effects of Tb4, it is still not clear how Tb4 exerts
its beneficial effects, is still under investigation. Although, Tb4i s
internalized by cells but the cell surface receptors are still not
known. Furthermore, high concentration and ubiquitous presence
Thymosin Beta 4 Prevents Oxidative Stress
PLoS ONE | www.plosone.org 11 October 2011 | Volume 6 | Issue 10 | e26912of Tb4 in the organs/tissues, it is reasonable to advocate that Tb4
functions as an important intracellular mediator when either
release from the cells or exogenously added, acts as a moonlighting
peptide for repairing the damages tissues or cells [56,57]. Our
results not only offered more mechanistic explanation about the
protective mechanism of Tb4 but also supported the need to
further investigate the use of this peptide in protecting the
myocardium against oxidative damage in variety of disease
condition where ROS has been implicated to play a damaging
role. Also, further investigations are needed to explore the anti-
fibrotic properties of Tb4 which could be used to alleviate
detrimental conditions like cardiac fibrosis, hypertrophy and heart
failure.
Clinical Implications
Many studies have shown that there is a depletion of anti-
oxidant levels due to aging especially in the heart, which makes it
more vulnerable to damage especially under ischemia and under
high pro-oxidant condition. We believe that the identified
molecules (Cu/Zn-SOD, catalase and Bcl2) are important players
under oxidative stress to mitigate the damage. Our findings
indicated that the beneficial role of Tb4 and its effects on
upregulation of anti-oxidant genes under oxidative stress in the
cardiac fibroblasts might be of clinical relevance. This makes Tb4
a better therapeutic target and could have wider implications once
translated from bench to bedside.
Limitation of the Study
In this study, we validated the effect of Tb4 by selectively
knocking down the anti-oxidant and apoptotic genes targeted by
Tb4 in cardiac fibroblasts. However, the possibility of interaction
between these genes and other molecular pathways cannot be
ignored. Also other off target effects of our anti-oxidative strategies
with Tb4 in conditions like cardiac fibrosis, cardiomyopathies and
heart failure needs to be further investigated.
Author Contributions
Conceived and designed the experiments: SG. Performed the experiments:
SK. Analyzed the data: SG SK. Wrote the paper: SG SK.
References
1. Dimmeler S, Zeiher AM (2007) A "reductionist" view of cardiomyopathy. Cell
130: 401–402.
2. Matata BM, Elahi MM (2007) Oxidative stress: clinical and biomedical
implications. New York: Nova Biomedical Books. vi. 330 p.
3. Sadoshima J (2006) Redox regulation of growth and death in cardiac myocytes.
Antioxid Redox Signal 8: 1621–1624.
4. Kukin ML, Fuster V (2003) Oxidative stress and cardiac failure. Armonk, NY:
Futura Pub. xx, 291.
5. Cohen J, Shah PM (1974) Cardiac hypertrophy and cardiomyopathy. Jules
Cohen, Pravin M. Shah, eds. Proceedings of a symposium held October 1972 in
Rochester, New York. New York: American Heart Assn. 223 p.
6. Dhalla AK, Singal PK (1994) Antioxidant changes in hypertrophied and failing
guinea pig hearts. Am J Physiol 266: H1280–1285.
7. Maron BJ, Salberg L (2006) Hypertrophic cardiomyopathy : for patients, their
families, and interested physicians. Malden, Mass.: Blackwell Pub. xi. 113 p.
8. Poornima IG, Parikh P, Shannon RP (2006) Diabetic Cardiomyopathy: The
Search for a Unifying Hypothesis. Circ Res 98: 596–605.
9. Chen Y, Saari JT, Kang YJ (1994) Weak antioxidant defenses make the heart a
target for damage in copper-deficient rats. Free Radical Biology and Medicine
17: 529–536.
10. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, et al. (1999) Mitochondrial
electron transport complex I is a potential source of oxygen free radicals in the
failing myocardium. Circ Res 85: 357–363.
11. George J, Struthers AD (2009) Role of urate, xanthine oxidase and the effects of
allopurinol in vascular oxidative stress. Vasc Health Risk Manag 5: 265–272.
12. Bubb MR (2003) Thymosin beta 4 interactions. Vitamins and hormones 66:
297–316.
13. Malinda KM, Goldstein AL, Kleinman HK (1997) Thymosin beta 4 stimulates
directional migration of human umbilical vein endothelial cells. The FASEB
journal: official publication of the Federation of American Societies for
Experimental Biology 11: 474–481.
14. Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D (2004)
Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell
migration, survival and cardiac repair. Nature 432: 466–472.
15. Smart N, Risebro CA, Clark JE, Ehler E, Miquerol L, et al. (2010) Thymosin
beta4 facilitates epicardial neovascularization of the injured adult heart. Annals
of the New York Academy of Sciences 1194: 97–104.
16. Qiu F-Y, Song X-X, Zheng H, Zhao Y-B, Fu G-S (2009) Thymosin [beta]4
Induces Endothelial Progenitor Cell Migration via PI3K/Akt/eNOS Signal
Transduction Pathway. Journal of Cardiovascular Pharmacology 53: 209–214
210.
17. Goldstein AL, Garaci E (2010) Thymosins in health and disease: 2nd
international symposium. Boston, Mass: Blackwell Pub. on behalf of the New
York Academy of Sciences. xi. 230 p.
18. Sosne G, Siddiqi A, Kurpakus-Wheater M (2004) Thymosin-{beta}4 Inhibits
Corneal Epithelial Cell Apoptosis after Ethanol Exposure In Vitro. Invest
Ophthalmol Vis Sci 45: 1095–1100.
19. Ho JH-C, Chuang C-H, Ho C-Y, Shih Y-RV, Lee OK-S, et al. (2007)
Internalization Is Essential for the Antiapoptotic Effects of Exogenous Thymosin
{beta}-4 on Human Corneal Epithelial Cells. Invest Ophthalmol Vis Sci 48:
27–33.
20. Sosne G, Albeiruti A-R, Hollis B, Siddiqi A, Ellenberg D, et al. (2006) Thymosin
[beta]4 inhibits benzalkonium chloride-mediated apoptosis in corneal and
conjunctival epithelial cells in vitro. Experimental Eye Research 83: 502–507.
21. Shrivastava S, Srivastava D, Olson EN, DiMaio JM, Bock-Marquette I (2010)
Thymosin beta4 and cardiac repair. Ann N Y Acad Sci 1194: 87–96.
22. Sopko N, Qin Y, Finan A, Dadabayev A, Chigurupati S, et al. (2011)
Significance of Thymosin beta4 and Implication of PINCH-1-ILK-alpha-Parvin
(PIP) Complex in Human Dilated Cardiomyopathy. PloS one 6: e20184.
23. Ho JH, Tseng KC, Ma WH, Chen KH, Lee OK, et al. (2008) Thymosin beta-4
upregulates anti-oxidative enzymes and protects human cornea epithelial cells
against oxidative damage. Br J Ophthalmol 92: 992–997.
24. Ieda M, Tsuchihashi T, Ivey KN, Ross RS, Hong T-T, et al. (2009) Cardiac
Fibroblasts Regulate Myocardial Proliferation through
21 Integrin Signaling.
Developmental cell 16: 233–244.
25. Leask A (2007) TGFb, cardiac fibroblasts, and the fibrotic response.
Cardiovascular research 74: 207–212.
26. Squires CE, Escobar GP, Payne JF, Leonardi RA, Goshorn DK, et al. (2005)
Altered fibroblast function following myocardial infarction. Journal of molecular
and cellular cardiology 39: 699–707.
27. Jelaska A, Strehlow D, Korn JH (1999) Fibroblast heterogeneity in physiological
conditions and fibrotic disease. Springer Semin Immunopathol 21: 385–395.
28. Brown RD, Ambler SK, Mitchell MD, Long CS (2005) The cardiac fibroblast:
therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol
Toxicol 45: 657–687.
29. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, et al. (2010) Cardiac
fibroblasts are essential for the adaptive response of the murine heart to pressure
overload. The Journal of clinical investigation 120: 254–265.
30. Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, et al. (2011)
Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial
Ischemia/Reperfusion Injury. Circulation 123(6): 594–604.
31. Gupta S, Purcell NH, Lin A, Sen S (2002) Activation of nuclear factor-kBi s
necessary for myotrophin-induced cardiac hypertrophy. The Journal of Cell
Biology 159: 1019–1028.
32. Schorb W, Booz G, Dostal D, Conrad K, Chang K, et al. (1993) Angiotensin II
is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72: 1245–1254.
33. Kumar S, Kain V, Sitasawad SL (2009) Cardiotoxicity of calmidazolium
chloride is attributed to calcium aggravation, oxidative and nitrosative stress,
and apoptosis. Free Radic Biol Med 47: 699–709.
34. Elia L, Contu R, Quintavalle M, Varrone F, Chimenti C, et al. (2009)
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal
transduction cascade in cardiac and skeletal muscle in physiological and
pathological conditions. Circulation 120: 2377–2385.
35. Livak KJ, Schmittgen TD (2001) Analysis of Relative Gene Expression Data
Using Real-Time Quantitative PCR and the 2-[Delta][Delta]CT Method.
Methods 25: 402–408.
36. Pfaffl MW (2001) A new mathematical model for relative quantification in real-
time RT–PCR. Nucleic Acids Research 29: e45.
37. Murata H, Ihara Y, Nakamura H, Yodoi J, Sumikawa K, et al. (2003)
Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt.
J Biol Chem 278: 50226–50233.
38. Han H, Long H, Wang H, Wang J, Zhang Y, et al. (2004) Progressive apoptotic
cell death triggered by transient oxidative insult in H9c2 rat ventricular cells: a
novel pattern of apoptosis and the mechanisms. Am J Physiol Heart Circ Physiol
286: H2169–2182.
39. Frank H, Thiel D, MacLeod J (1989) Mass spectrometric detection of cross-
linked fatty acids formed during radical-induced lesion of lipid membranes.
Biochem J 260: 873–878.
Thymosin Beta 4 Prevents Oxidative Stress
PLoS ONE | www.plosone.org 12 October 2011 | Volume 6 | Issue 10 | e2691240. Dean RT, Fu S, Stocker R, Davies MJ (1997) Biochemistry and pathology of
radical-mediated protein oxidation. Biochem J 324 ( Pt 1): 1–18.
41. Breen AP, Murphy JA (1995) Reactions of oxyl radicals with DNA. Free Radic
Biol Med 18: 1033–1077.
42. Murphy MP, Packer MA, Scarlett JL, Martin SW (1998) Peroxynitrite: a
biologically significant oxidant. Gen Pharmacol 31: 179–186.
43. Crawford DR, Davies KJ (1994) Adaptive response and oxidative stress. Environ
Health Perspect 102 Suppl 10: 25–28.
44. Pereira CV, Moreira AC, Pereira SP, Machado NG, Carvalho FS, et al. (2009)
Investigating drug-induced mitochondrial toxicity: a biosensor to increase drug
safety? Curr Drug Saf 4: 34–54.
45. Weiss JN, Korge P, Honda HM, Ping P (2003) Role of the mitochondrial
permeability transition in myocardial disease. Circ Res 93: 292–301.
46. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, et al. (2005) Loss of
cyclophilin D reveals a critical role for mitochondrial permeability transition in
cell death. Nature 434: 658–662.
47. MacMillan-Crow LA, Crow JP, Thompson JA (1998) Peroxynitrite-mediated
inactivation of manganese superoxide dismutase involves nitration and oxidation
of critical tyrosine residues. Biochemistry 37: 1613–1622.
48. Rahman K (2007) Studies on free radicals, antioxidants, and co-factors. Clin
Interv Aging 2: 219–236.
49. Huff T, Rosorius O, Otto AM, Muller CS, Ballweber E, et al. (2004) Nuclear
localisation of the G-actin sequestering peptide thymosin beta4. Journal of cell
science 117: 5333–5341.
50. Shen X, Ranallo R, Choi E, Wu C (2003) Involvement of actin-related proteins
in ATP-dependent chromatin remodeling. Molecular cell 12: 147–155.
51. Percipalle P, Zhao J, Pope B, Weeds A, Lindberg U, et al. (2001) Actin bound to
the heterogeneous nuclear ribonucleoprotein hrp36 is associated with Balbiani
ring mRNA from the gene to polysomes. The Journal of Cell Biology 153:
229–236.
52. Hori M, Nishida K (2009) Oxidative stress and left ventricular remodelling after
myocardial infarction. Cardiovasc Res 81: 457–464.
53. Young JD, Lawrence AJ, MacLean AG, Leung BP, McInnes IB, et al. (1999)
Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by
monocytes in the presence of glucocorticoids. Nature medicine 5: 1424–1427.
54. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, Diez-Marques L, Ortega-
Velazquez R, et al. (2001) Hydrogen peroxide increases extracellular matrix
mRNA through TGF-beta in human mesangial cells. Kidney Int 59: 87–95.
55. Suh JH, Shigeno ET, Morrow JD, Cox B, Rorcha AE, et al. (2001) Oxidative
stress in the aging rat heart is reversed by dietary supplementation with (R)-
{alpha}-lipoic acid. FASEB J 15: 700–706.
56. Goldstein AL, Hannappel E, Kleinman HK (2005) Thymosin beta4: actin-
sequestering protein moonlights to repair injured tissues. Trends in molecular
medicine 11: 421–429.
57. Crockford D, Turjman N, Allan C, Angel J (2010) Thymosin beta4: structure,
function, and biological properties supporting current and future clinical
applications. Annals of the New York Academy of Sciences 1194: 179–189.
Thymosin Beta 4 Prevents Oxidative Stress
PLoS ONE | www.plosone.org 13 October 2011 | Volume 6 | Issue 10 | e26912